A series of piperazinephen-1-ylehtylamines were synthesized and evaluated for their biological activity at the human melanocortin-4 receptor. This modification reduced the size and flexibility of the N-alkyl side-chain of some earlier lead compounds, while maintained the low nanomolar binding affinity.We have shown that a series of piperazinebenzylamines such as 1a are potent small molecule antagonists of the melanocortin-4 receptor (MC4R) [1], which could be potentially useful for the treatment of cachexia [2]. We have also demonstrated that compound 1b from this series is capable of inducing food intake in satiated mice by direct intracerebroventricular administration [3]. While 1a displays relatively good in vitro metabolic stability in human liver microsomes (CL int = 23 mL/min.kg) partly due to its high hydrophilicity (calculated and measured logD values are both 1.1), the more lipophilic 1b (cLogD = 4.0, CL int = 870 mL/min.kg) and its close analogues possess much higher intrinsic clearance. In addition, we have found that compound 1a is poorly absorbed after oral administration in rodents, probably due to its dibasic nature [4]. Recently, we discovered that the highly flexible and lipophilic 2-thienylethyl group in 1a could be effectively replaced by the smaller, hydrophilic 1-methoxy-2-propyl (i.e. compound 1c) without significant loss in potency [4]. In the same study, we found that the β-alanine moiety in 1c could be replaced by amides, carbamates or ureas, leading to monobasic compounds that displayed improved pharmacokinetic properties in rats.protocol to give the amides 8a-d. Deprotection of 8a-d with TFA gave the free amine intermediates 9a-d, which were converted to the amides 10a, carbamate 10b and ureas 10c according to the following procedures: peptide coupling reactions of 9a-d with a variety of carboxylic acids afforded 10a; reaction with ethyl chloroformate in the presence of triethylamine provided 10b; and treatment with phosgene in toluene, followed by an alkylamine gave the ureas 10c. Finally, reductive amination of 10a-c with various alkylamines provided the target molecules 2-4 (Scheme 1). When a N-Boc group was present in the carboxylic acid for 10a, TFA treatment was applied before the final purification.The chiral (R)-phenylethylamines 5 were synthesized as described in Scheme 2. Condensation of 2,5-difluorobenzaldehyde 6b with N-Boc-piperazine under heating in DMF gave the substituted piperazinebenzaldehyde 11 in moderate yield. Reaction of 11 with (R)-tertbutanesulfinamide in the presence of titanium tetraethoxide afforded the imine 12 in excellent yield, which was subjected to a methyllithium addition at low temperature (THF/-78 o C) to give the (R)-configured phen-1-ylethylamine 13 as the predominant product (2:1 ratio), [7] which was purified by column chromatography. The Boc-group in 13 was selectively removed with TFA in dichloromethane at 0 o C to room temperature, followed by a coupling reaction of the resulting free amine with (R)-N-Boc-(2,4-Cl)-dichlorophenylalanine using a...